In a strategic move, the Cendres+Métaux Group has successfully acquired 100% ownership of Lauener & Cie, a Boudry NE-based company specializing in high-precision turned parts for the watchmaking and medical technology sectors. The founders, Emmanuel and Caroline Raffner, with 14 years at the helm, decided to sell the company. CIC Capital (Suisse), a subsidiary of […]
Vail Resorts has revealed plans to acquire an 84% ownership stake in Remontées Mécaniques Crans Montana Aminona (CMA), the entity managing the renowned Crans-Montana Mountain Resort in Switzerland. This acquisition includes an 80% ownership share
Bär & Karrer advises Miele o the Establishment of a Joint Venture in the Fields of Infection Control and Life Science Miele and Metall Zug have reached an agreement outlining the establishment of a
Niederer Kraft Frey played a key role in advising the Sonio group on its recent acquisition of JevoTrust Management, marking a strategic move in the Swiss market. Sonio, previously known as Infoniqa SQL, stands as
In a strategic move to expand its presence in the cloud and managed services sector, funds advised by Bregal Unternehmerkapital (Bregal) have successfully acquired Netrics Group, one of Switzerland’s leading providers in this space,
Kohlberg Kravis Roberts (KKR) makes a significant investment into the Precipart Group, a renowned contract manufacturer of high-precision components to the medical, aerospace and industrial markets. KKR plans to support the company in its continued
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
In a transaction that echoes the essence of refined heritage, Gérard and Nadia Dominicé have gracefully secured ownership of seven parcels in the picturesque commune of Genthod, nestled within the canton of Geneva. This
Waterland Private Equity, along with the minority stakeholders of Netrics Holding, has formalized a share purchase agreement for the divestment of all shares in Netrics Group to Bregal Unternehmerkapital, a global private equity firm. Netrics
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
